GEN Exclusives

More »

GEN News Highlights

More »
Aug 30, 2007

SAFC to Expand High-Potency API Manufacturing

  • SAFC reports plans for a $4.5 million capacity expansion program at its flagship SAFC Pharma high-potency API (HPAPI) facility in Madison, WI. The project, scheduled for commission in early 2008, will add cGMP pilot plant and kilo lab capacity, the company points out.

    These developments build upon existing capabilities in potent compound handling at the Safebridge®-certified SAFC Madison facility and add to a $12 million, 38,000 sq. ft. expansion program completed in 2006. Specifically, SAFC will add two 400 L cGMP pilot plant reactors and two 100 L cGMP portable jacketed reactors into a 1,200 sq. ft. dedicated, large-scale kilo lab.

    The company says that this will enable larger-scale chromatography for process purification. It also will complement the new XRPD (X-ray Powder Diffraction) analytical equipment for advanced solid form testing due to become operational this month.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?